Need professional-grade analysis? Visit stockanalysis.com
$4.35B
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Diagnósticos da América S.A (DASA3) Price Performance
Diagnósticos da América S.A (DASA3) trades on SA in BRL. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at BRL3.71, up 18.91% from the previous close.
Over the past year, DASA3 has traded between a low of BRL1.20 and a high of BRL4.60. The stock has gained 74.2% over this period. It is currently 19.3% below its 52-week high.
Diagnósticos da América S.A has a market capitalization of $4.35B.
About Diagnósticos da América S.A
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. It operates through Hospitals and Oncology; Diagnostics and Care Coordination; and International Diagnostics segments. The company offers outpatient doctors; medical and outpatient services; diagnostic support assistants for private patients or partner companies; care coordination, remote monitoring, population health management, home medical, and paramedical services; and medical consultations. It is also involved in the development and licensing of computer programs and predictive models using information technology and data science; and brokerage activities. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was founded in 1961 and is headquartered in Barueri, Brazil.
Company Info
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- SA
- Currency
- BRL
- Country
- Brazil
Financial Metrics
- Revenue (TTM)
- $12.57B
- EBITDA
- $1.84B
- Profit Margin
- -8.18%
- EPS (TTM)
- -0.62
- Book Value
- 6.26
Technical Indicators
- 52 Week High
- R$4.77
- 52 Week Low
- R$1.18
- 50 Day MA
- R$1.82
- 200 Day MA
- R$1.62
- Beta
- 0.51
Valuation
- Trailing P/E
- N/A
- Forward P/E
- 50.00
- Price/Sales
- 0.38
- Price/Book
- 0.57
- Enterprise Value
- $11.76B